PSMA6 and liver disorder: In a prespecified subgroup analysis (Fig 4), no significant differences were found according to age of >85 years, diabetes, neurological disease, renal failure, liver disease, treatment with alpha 1 blockers, and treatment with oral steroids; however, the results were similar in the other groups.